Latest news with #Alzheimer'sDisease
Yahoo
2 days ago
- Health
- Yahoo
This Popular Supplement May Help With Alzheimer's Symptoms
Creatine is everywhere on social media right now, with recs coming from influencers and health experts. Research is starting to find that the popular supplement can do more than help you build muscle. In a small pilot trial published in a journal, researchers found that creatine monohydrate may help improve cognitive function in individuals with Alzheimer's Disease. It's hard to cruise your For You feed right now without being faced with yet another testimonial about the perks of taking a creatine supplement. While creatine is the supplement du jour, there is solid data to support its use—mostly around fitness. But a growing body of research suggests that creatine may do more than help you build muscles, including easing depression and helping with brain fog after a bad night's sleep. Now, a new study suggests that there may be some benefit to using creatine to boost cognition in people with Alzheimer's disease. The research is very early and this is technically a pilot trial (which is basically a trial run). But the findings bring up a number of questions about whether something as simple as adding a creatine supplement could help improve symptoms in people with such a devastating condition. Here's what the study, found plus what doctors and nutritionists recommend keeping in mind. Meet the experts: Amit Sachdev, MD, is the medical director in the Department of Neurology at Michigan State University; Albert Matheny, RD, CSCS, is co-founder of SoHo Strength Lab; Matthew Taylor, PhD, RD, is a study co-author, assistant professor, and director of the KU Brain Nutrition Laboratory at University of Kansas Medical Center; Clifford Segil, DO, is a neurologist at Providence Saint John's Health Center in Santa Monica, CA The study, which was published in the journal Alzheimer's & Dementia Translational Research & Clinical Interventions, looked into the 'feasibility' of patients with Alzheimer's disease taking 20 grams a day of creatine monohydrate (the most widely studied form of creatine) for eight weeks. The researchers looked at how compliant the patients were (i.e. how likely they were to take the supplement). They also monitored levels of creatine in the patients' blood at the start, four weeks, and eight weeks later, along with levels of creatine in their brains. They also tested the patients' cognition at the start of the study and after eight weeks. The researchers found that 19 of the 20 participants were more than 80 percent compliant with taking the creatine during the study. They also found that creatine levels went up in their blood after four and eight weeks, and that creatine in the brain increased by 11 percent. And here's the really interesting part: The researchers discovered that the patients had better improvements in cognitive tests, including sorting and reading, along with tests to measure attention and response, after eight weeks of creatine supplementation. The researchers concluded that the findings provide 'preliminary evidence' for more research. 'We decided to do this study because there were a couple of recent studies in mice suggesting that, in a mouse model of Alzheimer's, creatine monohydrate supplementation may be beneficial,' says study co-author Matthew Taylor, PhD, RD, assistant professor and director of the KU Brain Nutrition Laboratory at University of Kansas Medical Center. 'Prior to this study, no work had been done in humans with Alzheimer's, so it was the right time to start looking at it as a potentially beneficial supplement for Alzheimer's.' The study didn't look into this, but there are some theories. 'The brain requires a lot of energy, but in Alzheimer's, brain energy metabolism drastically declines,' Taylor explains. 'Creatine is a very important substance for transporting energy produced by our mitochondria and increasing creatine levels may even encourage mitochondria to produce more energy.' Albert Matheny, RD, CSCS, co-founder of SoHo Strength Lab, co-signs that theory. Creatine helps to produce adenosine triphosphate (ATP), 'and ATP is the brain's primary energy source,' he says. Adding more creatine to the body could, in theory, help support cognition in people with Alzheimer's disease, Matheny adds. Creatine may also have other roles, like decreasing inflammation and oxidative stress in the body, which could potentially help with symptoms of Alzheimer's disease, Taylor says. 'Each of these roles could help with cognitive function in Alzheimer's, but we still have so much to learn about the roles of this molecule in the brain,' he says. We're not there yet. Again, this was a pilot study and it simply found that people who have Alzheimer's disease may be able to regularly take creatine supplements and might have a boost in cognition as a result. But this doesn't mean that people with Alzheimer's disease should take creatine, says Amit Sachdev, MD, medical director in the Department of Neurology at Michigan State University. 'I would not advise the use of creatine with the goal of improving cognition,' he says, noting that there's not yet 'well-established data to support this use.' Clifford Segil, DO, a neurologist at Providence Saint John's Health Center in Santa Monica, CA, agrees. "We are not at a point that creatine supplementation for brain health is an accepted supplement," he says. Taylor agrees. 'Our study is far from a definitive study,' he says. 'Well-designed, placebo-controlled clinical trials are needed to determine whether creatine is beneficial for Alzheimer's. I would suggest Alzheimer's patients and their families discuss taking any supplement with their neurologist.' You Might Also Like Can Apple Cider Vinegar Lead to Weight Loss? Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50
Yahoo
6 days ago
- Entertainment
- Yahoo
Phil Robertson's Cause of Death Unclear, But Health Issues Were Escalating
Phil Robertson, the patriarch of the Duck Dynasty family, has died, his daughter-in-law and son confirmed on social media. "My dad has gone to be with the Lord today! He will be missed but we know he is in good hands, and our family is good because God is very good! We will see him again! #PhilRobertson #Jesus," Robertson's son, Jase Robertson, wrote on X. They did not reveal an official cause of death. However, Phil Robertson's health issues are well-known; he had a highly publicized battle with Alzheimer's disease, according to KSBV-TV. According to People, Robertson's Alzheimer's diagnosis was revealed in December. He was 79. In a podcast in December, Jase revealed that his dad's Alzheimer's Disease was getting worse. "He's just not doing well. He's really struggling," he said. In April, he shared, "We're making him comfortable, and we're doing the best we can. I think that's just what you do." TMZ reported that Phil Robertson was also "suffering from a blood disease that was causing health issues." Korie Robertson, who is married to Willie Robertson, Phil Robertson's son, posted a lengthy tribute on Facebook. "We celebrate today that our father, husband, and grandfather, Phil Robertson, is now with the Lord. He reminded us often of the words of Paul, 'you do not grieve like those who have no hope. For we believe that Jesus died and rose again, and so we believe that God will bring with Jesus those who have fallen asleep in him,'" she wrote on Facebook on May 25, 2025."Thank you for the love and prayers of so many whose lives have been impacted by his life saved by grace, his bold faith, and by his desire to tell everyone who would listen the Good News of Jesus. We are grateful for his life on earth and will continue the legacy of love for God and love for others until we see him again," she added. According to Korie Robertson: "We know so many of you love him and have been impacted by his life. We're having a private service for now, but we'll share details soon about a public celebration of his life." The post was signed, "The Robertson Family," and concluded with a Bible verse: "1 Corinthians 2."People reported that Duck Dynasty, which showcased the family, ended in 2017. According to TMZ, Phil Robertson was a controversial figure over the years, once suspended in 2014 for remarks he made in an Robertson's Cause of Death Unclear, But Health Issues Were Escalating first appeared on Men's Journal on May 26, 2025
Scottish Sun
23-05-2025
- Entertainment
- Scottish Sun
Fiona Phillips seen for the first time in a YEAR as she bravely battles Alzheimer's
The TV favourite previously spoke candidly about her diagnosis keep smiling Fiona Phillips seen for the first time in a YEAR as she bravely battles Alzheimer's FIONA Phillips has been seen for the first time in over a YEAR as she continues to bravely battle Alzheimer's. The broadcaster and TV presenter, 64, was diagnosed with the disease in 2022, and shared her health news publicly in 2023. 5 Fiona Phillips has been seen for the first time in over a year amid her Alzheimer's battle 5 The broadcaster was diagnosed with the disease in 2022 Credit: Getty 5 Fiona was last seen at Kate Garraway's husband Derek Draper's funeral last February Credit: Getty Fiona was seen smiling in a new snap to promote her upcoming book, Remember When: My Life with Alzheimer's. The journalist was seen with her husband and former This Morning producer Martin Frizell, 66, at Kate Garraway's late husband Derek Draper's funeral last February. In the new photo, Fiona was dressed in a beige turtle neck jumper with a black coat as she posed for a photo in the street. The memoir, which which will be released on July 3 through publishers Pan Macmillan, will teach the important insight into living with the disease in the hope that it will help others. Fiona had cared for her parents who had both suffered from the disease and is now facing the same diagnosis. The TV favourite previously spoke candidly about her diagnosis. She said: 'I wonder if all the years of getting up so early contributed to me developing Alzheimer's so young. "Getting my diagnosis was devastating.' She is now taking part in a clinical trial for a new treatment and said the 'signs are positive'. Lorraine Kelly pays tribute to 'quite amazing' Fiona Phillips following devastating Alzheimer's Disease diagnosis In an interview with the Woman & Home magazine, she added: 'It involves a brand new drug and a placebo. 'I have no idea which one I am on. 'When I went for my six-month check-up, they did cognitive tests to see where my brain was at, which showed I was in the same place as I was the previous year. 'I'm hopeful that the drug is holding the disease where it is.' Despite the diagnosis, Fiona says she is trying to keep positive. She added: 'I'm not giving it any space in my life at the moment. 'I've still got so much I want to do. 'I'd rather this hadn't happened but it has and I'm going to deal with it in the best way I can. 'I am determined to live the best life I can.' Fiona has two sons, Nathaniel, 25, and Mackenzie, 22, with husband Martin Frizell. She said: 'My sons have been incredible about my diagnosis. 'I thought they may be scared or treat me differently, but I couldn't have asked for a better reaction. 'They're much more affectionate with me now, and they'll sit and cuddle me while we're watching telly. It's lovely.' Fiona started her broadcasting career at local radio stations before becoming a presenter for CNN. She appeared as a panellist on Loose Women, and has been a reporter on Watchdog and helmed Lorraine. Fiona is best known for being the lead anchor alongside Eamonn Holmes on GMTV in the 90s and early noughties. She joined the show in 1993 as entertainment correspondent, but hit the big time when she was promoted to being the ITV breakfast show's main host. But in August 2008, Fiona announced that she was to leave GMTV for "family reasons". She said: "I love the job but I've got other responsibilities - the children, a home life and an elderly dad who needs me - and I've recognised that I can't have it all." She presented her final show on December 18, 2008. In January 2022, she revealed that she was too frightened to return to TV due to an ongoing battle with "brain fog" during menopause. When has Fiona Phillips said about being diagnosed with Alzheimer's? In July 2023, Fiona Phillips revealed that she has been diagnosed with Alzheimer's at the age of 62. She told the Mirror: "This disease has ravaged my family and now it has come for me. And all over the country there are people of all different ages whose lives are being affected by it - it's heartbreaking. I just hope I can help find a cure which might make things better for others in the future." She continued: 'It's something I might have thought I'd get at 80. 'But I was still only 61 years old. 'I felt more angry than anything else because this disease has already impacted my life in so many ways; my poor mum was crippled with it, then my dad, my grandparents, my uncle. It just keeps coming back for us.' 5 Fiona is married to former This Morning producer Martin Frizell Credit: Getty
The Irish Sun
23-05-2025
- Entertainment
- The Irish Sun
Fiona Phillips seen for the first time in a YEAR as she bravely battles Alzheimer's
FIONA Phillips has been seen for the first time in over a YEAR as she continues to bravely battle Alzheimer's. The broadcaster and TV presenter, 64, was diagnosed with the disease in 2022, and shared her health news publicly in 2023. 5 Fiona Phillips has been seen for the first time in over a year amid her Alzheimer's battle 5 The broadcaster was diagnosed with the disease in 2022 Credit: Getty 5 Fiona was last seen at Kate Garraway's husband Derek Draper's funeral last February Credit: Getty The journalist was seen with her husband and former This Morning producer Martin Frizell, 66, at Kate Garraway's late husband Derek Draper's funeral last February. In the new photo, Fiona was dressed in a beige turtle neck jumper with a black coat as she posed for a photo in the street. The memoir, which which will be released on July 3 through publishers Pan Macmillan, will teach the important insight into living with the disease in the hope that it will help others. READ MORE ON FIONA PHILLIPS Fiona had cared for her parents who had both suffered from the disease and is now facing the same diagnosis. The TV favourite previously spoke candidly about her diagnosis. She said: 'I wonder if all the years of getting up so early contributed to me "Getting Most read in News TV She is now taking part in a clinical trial for a new treatment and said the 'signs are positive'. Lorraine Kelly pays tribute to 'quite amazing' Fiona Phillips following devastating Alzheimer's Disease diagnosis In an interview with the Woman & Home magazine, she added: 'It involves a brand new drug and a placebo. 'I have no idea which one I am on. 'When I went for my six-month check-up, they did cognitive tests to see where my brain was at, which showed I was in the same place as I was the previous year. 'I'm hopeful that the drug is holding the disease where it is.' Despite She added: 'I'm not giving it any space in my life at the moment. 'I've still got so much I want to do. 'I'd rather this hadn't happened but it has and I'm going to deal with it in the best way I can. 'I am determined to live the best life I can.' Fiona has two sons, Nathaniel, 25, and Mackenzie, 22, with husband Martin Frizell. She said: 'My sons have been incredible about my diagnosis. 'I thought they may be scared or treat me differently, but I couldn't have asked for a better reaction. 'They're much more affectionate with me now, and they'll sit and cuddle me while we're watching telly. It's lovely.' Fiona started her broadcasting career at local radio stations before becoming a presenter for CNN. She appeared as a panellist on Loose Women, and has been a reporter on Watchdog and helmed Lorraine. Fiona is best known for being the lead anchor alongside Eamonn Holmes on GMTV in the 90s and early noughties. She joined the show in 1993 as entertainment correspondent, but hit the big time when she was promoted to being the ITV breakfast show's main host. But in August 2008, Fiona announced that she was to leave GMTV for "family reasons". She said: "I love the job but I've got other responsibilities - the children, a home life and an elderly dad who needs me - and I've recognised that I can't have it all." She presented her final show on December 18, 2008. In January 2022, she revealed that she was When has Fiona Phillips said about being diagnosed with Alzheimer's? In July 2023, Fiona Phillips revealed that she has been diagnosed with Alzheimer's at the age of 62. She told She continued: 'It's something I might have thought I'd get at 80. 'But I was still only 61 years old. 'I felt more angry than anything else because this disease has already impacted my life in so many ways; my poor mum was crippled with it, then my dad, my grandparents, my uncle. It just keeps coming back for us.' 5 Fiona is married to former This Morning producer Martin Frizell Credit: Getty 5 Fiona has been a familiar face on our screen for over 30 years Credit: Rex
The Market Online
23-05-2025
- Business
- The Market Online
Algernon closes NoBrainer acquisition
Algernon Pharmaceuticals (CSE:AGN) has officially closed its acquisition of NoBrainer Imaging Centres, Inc., marking a significant expansion into the Alzheimer's Disease diagnostic and treatment market Algernon issued 5.5 million common shares and 5.5 million common share purchase warrants NoBrainer brings with it C$250,000 in working capital and a deposit on a Positrigo NeuroLF PET scanner Algernon Pharmaceuticals stock (CSE:AGN) last traded at $0.09 Microcap penny stock Algernon Pharmaceuticals (CSE:AGN) has officially closed its acquisition of NoBrainer Imaging Centres, Inc., marking a significant expansion into the Alzheimer's Disease diagnostic and treatment market. The transaction can position the clinical-stage pharmaceutical developer at the forefront of neurological healthcare innovation. Under the terms of the deal outlined in a media statement, Algernon has acquired 100 per cent of the issued and outstanding shares of NoBrainer, a Canadian company holding exclusive master franchise rights from NoBrainer Alzheimer's Treatment Centres, Inc. These rights cover all of Canada—excluding Oakville and Ottawa—and key U.S. markets including Florida (excluding Miami), Los Angeles, and five additional major cities. NoBrainer brings with it C$250,000 in working capital and a deposit on a Positrigo NeuroLF PET scanner, a cutting-edge brain imaging device expected to be delivered to Algernon's first U.S. clinic in Q4 2025. Transaction details The acquisition was executed through share exchange agreements signed on May 12, 2025. As consideration, Algernon issued: 5.5 million common shares and 5.5 million common share purchase warrants and 450,000 preferred shares and 450,000 preferred share purchase warrants (to be issued within six months pending shareholder approval) The common warrants are exercisable in stages over a five-year period, with escalating prices from $0.15 to $0.50 per share. Preferred shares, once approved, will be convertible into ten common shares each and carry a 10% annual dividend payable in shares. Preferred warrants follow a similar escalating price structure, ranging from $1.50 to $5.00 per share. All NoBrainer shareholders have signed voting support agreements in favor of Algernon, ensuring a smooth transition and alignment with the company's strategic goals. Algernon plans to expedite its annual meeting to secure shareholder approval for the preferred share issuance and will seek Canadian Securities Exchange (CSE) approval to list the new securities. The company is also exploring a preferred stock unit dividend or rights offering to bolster shareholder participation and meet listing requirements. Algernon Pharmaceuticals stock (CSE:AGN) last traded at $0.09. While it has risen 28.57 per cent since the year began, it has lost 43.75 per cent since this time last year. Join the discussion: Find out what everybody's saying about this microcap penny stock on the Algernon Pharmaceuticals Bullboard, and check out the rest of Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
